{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:37:32Z","timestamp":1791221852541,"version":"4.1.0"},"reference-count":60,"publisher":"American Physiological Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Endocrinology and Metabolism"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:p> Serum levels of the adrenal androgen dehydroepiandrosterone (DHEA) peak in men and women in the third decade of life and decrease progressively with age. Increasing numbers of middle-aged and older individuals consume over-the-counter preparations of DHEA, hoping it will retard aging by increasing muscle and bone mass and strength, decreasing fat, and improving immunologic and neurobehavioral functions. Because DHEA can serve as a precursor to more potent androgens and estrogens, like testosterone (T), dihydrotestosterone (DHT), and 17\u03b2-estradiol (E<jats:sub>2<\/jats:sub>), supplemental DHEA use may pose a cancer risk in patients with nascent or occult prostate cancer. The steroid-responsive human LNCaP prostate cancer cells, containing a functional but mutated androgen receptor (AR), were used to compare effects of DHEA with those of T, DHT, and E<jats:sub>2<\/jats:sub> on cell proliferation and protein and\/or gene expression of AR, prostate-specific antigen (PSA), IGF-I, IGF-I receptor (IGF-IR), IGF-II, IGF-binding proteins-2, -3, and -5, (IGFBPs-2, -3, and -5), and estrogen receptor-\u03b2 (ER\u03b2). Cell proliferation assays revealed significant stimulation by all four steroids. DHEA- and E<jats:sub>2<\/jats:sub>-induced responses were similar but delayed and reduced compared with that of T and DHT. All four hormones increased gene and\/or protein expression of PSA, IGF-IR, IGF-I, and IGFBP-2 and decreased that of AR, ER\u03b2, IGF-II, and IGFBP-3. There were no significant effects of hormone treatment on IGFBP-5 mRNA. DHEA and E<jats:sub>2<\/jats:sub> responses were similar, and distinct from those of DHT and T, in time- and dose-dependent studies. Further studies of the mechanisms of DHEA effects on prostate cancer epithelial cells of varying AR status, as well as on prostate stromal cells, will be required to discern the implications of DHEA supplementation on prostatic health. <\/jats:p>","DOI":"10.1152\/ajpendo.00454.2004","type":"journal-article","created":{"date-parts":[[2004,11,9]],"date-time":"2004-11-09T21:58:47Z","timestamp":1100037527000},"page":"E573-E584","source":"Crossref","is-referenced-by-count":89,"title":["Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells"],"prefix":"10.1152","volume":"288","author":[{"given":"Julia T.","family":"Arnold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanh","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly K.","family":"McFann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc R.","family":"Blackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"24","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.07.035"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00000744"},{"key":"R3","unstructured":"AlesciS, Manoli I, and Blackman MR. Dehydrodepiandrosterone. In: Encyclopedia of Dietary Supplements, edited by Coates P, Blackman MR, Cragg G, Levine M, Moss J, and White J. New York: Marcel Dekker. In press."},{"key":"R4","unstructured":"ArnoldJT, Lessey BA, Seppala M, and Kaufman DG. Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells. Cancer Res 62: 79\u201388, 2002."},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1990.tb34282.x"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(88)90157-8"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2003.09.001"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(97)00056-3"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(97)00092-0"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1210\/endo.138.11.5497"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1210\/endo.136.5.7536668"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.20.11173"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1420407"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1000777"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"CohenP, Peehl DM, Stamey TA, Wilson KF, Clemmons DR, and Rosenfeld RG. Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab 76: 1031\u20131035, 1993.","DOI":"10.1210\/jcem.76.4.7682560"},{"key":"R16","unstructured":"ComstockGW, Gordon GB, and Hsing AW. The relationship of serum dehydroepiandrosterone and its sulfate to subsequent cancer of the prostate. Cancer Epidemiol Biomarkers Prev 2: 219\u2013221, 1993."},{"key":"R17","unstructured":"CoreyE, Quinn JE, Emond MJ, Buhler KR, Brown LG, and Vessella RL. Inhibition of androgen-independent growth of prostate cancer xenografts by 17beta-estradiol. Clin Cancer Res 8: 1003\u20131007, 2002."},{"key":"R18","doi-asserted-by":"crossref","unstructured":"CuligZ, Hobisch A, Cronauer MV, Cato AC, Hittmair A, Radmayr C, Eberle J, Bartsch G, and Klocker H. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol Endocrinol 7: 1541\u20131550, 1993.","DOI":"10.1210\/mend.7.12.8145761"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(95)00230-8"},{"key":"R20","unstructured":"De LaunoitY, Veilleux R, Dufour M, Simard J, and Labrie F. Characteristics of the biphasic action of androgens and of the potent antiproliferative effects of the new pure antiestrogen EM-139 on cell cycle kinetic parameters in LNCaP human prostatic cancer cells. Cancer Res 51: 5165\u20135170, 1991."},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1210\/endo.140.3.6585"},{"key":"R22","unstructured":"GellerJ. Rationale for blockade of adrenal as well as testicular androgens in the treatment of advanced prostate cancer. Semin Oncol 12: 28\u201335, 1985."},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1210\/endo.140.10.7038"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"GnanapragasamVJ, McCahy PJ, Neal DE, and Robson CN. Insulin-like growth factor II and androgen receptor expression in the prostate. BJU Int 86: 731\u2013735, 2000.","DOI":"10.1046\/j.1464-410x.2000.00874.x"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(99)00122-7"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1210\/endo.140.5.6702"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.11.6990"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199707)182:3<356::AID-PATH863>3.0.CO;2-U"},{"key":"R29","unstructured":"HoroszewiczJ, Leong S, Kawinski E, Karr J, Rosenthal H, Chu T, Mirand E, and Murphy G. LNCaP model of human prostatic carcinoma. Cancer Res 43: 1809\u20131818, 1983."},{"key":"R30","unstructured":"IsaacsJT. The aging ACI\/Seg versus Copenhagen male rat as a model system for the study of prostatic carcinogenesis. Cancer Res 44: 5785\u20135796, 1984."},{"key":"R31","doi-asserted-by":"crossref","unstructured":"KleinH, Bressel M, Kastendieck H, and Voigt KD. Androgens, adrenal androgen precursors, and their metabolism in untreated primary tumors and lymph node metastases of human prostatic cancer. Am J Clin Oncol 11, Suppl 2: S30\u2013S36, 1988.","DOI":"10.1097\/00000421-198801102-00008"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1080\/01485010151094010"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-128X(98)00007-5"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1006\/frne.2001.0216"},{"key":"R35","unstructured":"LatilA, Bieche I, Vidaud D, Lidereau R, Berthon P, Cussenot O, and Vidaud M. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. Cancer Res 61: 1919\u20131926, 2001."},{"key":"R36","unstructured":"MaggioliniM, Donze O, Jeannin E, Ando S, and Picard D. Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha. Cancer Res 59: 4864\u20134869, 1999."},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.520"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(94)90056-6"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031847"},{"key":"R40","unstructured":"Martin-Du PanRC. [Are the hormones of youth carcinogenic?] Ann Endocrinol (Paris) 60: 392\u2013397, 1999."},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0045(19980301)34:4<283::AID-PROS6>3.0.CO;2-I"},{"key":"R42","unstructured":"NickersonT, Chang F, Lorimer D, Smeekens SP, Sawyers CL, and Pollak M. In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR). Cancer Res 61: 6276\u20136280, 2001."},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)45198-6"},{"key":"R44","doi-asserted-by":"crossref","unstructured":"OrentreichN, Brind JL, Vogelman JH, Andres R, and Baldwin H. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab 75: 1002\u20131004, 1992.","DOI":"10.1210\/jcem.75.4.1400863"},{"key":"R45","doi-asserted-by":"crossref","unstructured":"PeehlDM, Cohen P, and Rosenfeld RG. The insulin-like growth factor system in the prostate. World J Urol 13: 306\u2013311, 1995.","DOI":"10.1007\/BF00185974"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-40-3-373"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1630487"},{"key":"R48","unstructured":"RaoKV, Johnson WD, Bosland MC, Lubet RA, Steele VE, Kelloff GJ, and McCormick DL. Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone. Cancer Res 59: 3084\u20133089, 1999."},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0045(19981101)37:3<149::AID-PROS4>3.0.CO;2-E"},{"key":"R50","doi-asserted-by":"crossref","unstructured":"SchwartzAG and Pashko LL. Cancer prevention with dehydroepiandrosterone and non-androgenic structural analogs. J Cell Biochem Suppl 22: 210\u2013217, 1995.","DOI":"10.1002\/jcb.240590826"},{"key":"R51","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-128X(98)00054-3"},{"key":"R52","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61666-5"},{"key":"R53","unstructured":"SotoAM, Lin TM, Sakabe K, Olea N, Damassa DA, and Sonnenschein C. Variants of the human prostate LNCaP cell line as tools to study discrete components of the androgen-mediated proliferative response. Oncol Res 7: 545\u2013558, 1995."},{"key":"R54","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-218-44285"},{"key":"R55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505253322101"},{"key":"R56","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(92)90401-4"},{"key":"R57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.111150898"},{"key":"R58","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031560"},{"key":"R59","doi-asserted-by":"publisher","DOI":"10.1210\/endo.140.7.6769"},{"key":"R60","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)68158-X"}],"container-title":["American Journal of Physiology-Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajpendo.00454.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T14:35:45Z","timestamp":1567953345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajpendo.00454.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1152\/ajpendo.00454.2004"],"URL":"https:\/\/doi.org\/10.1152\/ajpendo.00454.2004","relation":{},"ISSN":["0193-1849","1522-1555"],"issn-type":[{"value":"0193-1849","type":"print"},{"value":"1522-1555","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}